FDA Exploring Over-the-Counter Access to Vaginal Estrogen
The FDA says it is working with sponsors to explore over-the-counter availability of vaginal estrogen. Here’s what that could mean for vaginal dryness and other menopause symptoms.
The FDA says it is working with sponsors to explore over-the-counter availability of vaginal estrogen. Here’s what that could mean for vaginal dryness and other menopause symptoms.
HHS announced that the FDA approved updated labeling for three more estradiol patch products, removing boxed warning statements, and gave an update on hormone therapy supply and access.
An executive order signed October 19, 2026 creates a Women’s Health Division at NIH and a White House Women’s Health Task Force, and names menopause among the areas needing more research.
ACOG issued its most comprehensive menopause guidance yet, strongly recommending hormone therapy for hot flashes and sleep problems and expanding advice on nonhormonal treatments, mood and sleep.
The American College of Physicians issued a new guideline recommending estrogen-based hormone therapy as first-line treatment for menopausal hot flashes and night sweats, with ranked nonhormonal alternatives.
The VA and Defense Department released a joint menopause clinical practice guideline with 43 recommendations for diagnosing and treating perimenopause and menopause symptoms.
The FDA held a public workshop on testosterone use in menopausal women. No testosterone product is approved for women, and the comment period has closed. Here’s what was discussed and what comes next.
In a historic move, the FDA has requested the removal of the black box warning from hormone therapy used for menopause. Experts say this long-overdue update reflects modern science—and could help women reclaim access to safe, effective symptom relief.
A major 2024 review of the Women’s Health Initiative has rewritten the story on hormone therapy. For women under 60 or within 10 years of menopause, the benefits may outweigh the risks—marking a turning point in how doctors and patients approach treatment.
A major study reveals women’s heart health declines rapidly after menopause, making this a crucial time for screening, prevention, and awareness.